This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Journalology/ Peer Review/ Authorship  • Dermatology, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Arch Dermatol. 2006;142:93-95.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

This issue of the ARCHIVES is the second entirely dedicated to Medical Dermatology. It is easy to see from the articles in this issue that Callen and Robinson¹ are right to assert that "Medical Dermatology Is Alive and Well." This issue also proves that a lot of patients are Alive and Well, thanks to the care of Medical Dermatologists. In this issue, Medical Dermatologists report on better treatments for patients afflicted with dermatomyositis, necrobiosis lipoidica, and livedoid vasculopathy. There are studies on cutaneous diseases that are associated with arthritis, breast cancer, and leukemia. There are also reports on identifying and preventing adverse reactions to prednisone and mycophenolate mofetil. Even a cursory review of this issue reveals that Medical Dermatologists are on the front lines of identifying and treating diseases with important systemic implications.

As the president of the Medical Dermatology Society (MDS) (http://www.meddermsociety.org), I am happy to . . . [Full Text of this Article]

AUTHOR INFORMATION
Michael P. Heffernan, MD

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?